Cholinesterase inhibitor use in U.S. nursing homes: Results from the national nursing home survey

Journal of the American Geriatrics Society

Volumn 57, Issue 12, 2009, Pages 2269-2274

  Seitz, Dallas P ^a,b,c   Gruneir, Andrea ^b,c   Conn, David K ^a   Rochon, Paula A ^b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b Kunin Lunenfeld Applied Research Unit and Department of Food and Nutrition Services and Baycrest Centre for Geriatric Care   (Canada)

^c WOMEN S COLLEGE HOSPITAL   (Canada)

Author keywords

Alzheimer's disease; Cholinesterase inhibitors; Dementia; Nursing homes

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT; RIVASTIGMINE;

AGE DISTRIBUTION; AGED; ARTICLE; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; DEMENTIA; DISEASE SEVERITY; DRUG UTILIZATION; FEMALE; HEALTH SURVEY; HUMAN; IMMOBILIZATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NURSING HOME; NURSING HOME PATIENT; PRESCRIPTION; TREATMENT DURATION; UNITED STATES;

AGED; AGED, 80 AND OVER; CHOLINESTERASE INHIBITORS; CROSS-SECTIONAL STUDIES; DEMENTIA; DRUG UTILIZATION; FEMALE; HEALTH CARE SURVEYS; HUMANS; MALE; NURSING HOMES; UNITED STATES;

EID: 71549116409     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2009.02552.x     Document Type: Article

References (30)

1. Bernstein AB, Remsburg RE. Estimated prevalence of people with cognitive impairment: Results from nationally representative community and institutional surveys. Gerontologist 2007 47 : 350 354.
2. Matthews FE, Dening T UK Medical Research Council Cognitive Function and Ageing Study. Prevalence of dementia in institutional care. Lancet 2002 360 : 225 226.
3. Lanctot KL, Herrmann N, Yau KK et al. Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: A meta-analysis. CMAJ 2003 169 : 557 564.
4. Hogan Db M, Bailey PM, Black SM et al. Diagnosis and treatment of dementia: 5. Nonpharmacologic and pharmacologic therapy for mild to moderate dementia. CMAJ 2008 179 : 1019 1026.
5. Birks J. Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev, 2006; CD005593.
6. Bocti C, Black S, Frank C. Management of dementia with a cerebrovascular component. Alzheimers Dement 2007 3 : 398 403.
7. Wild R, Pettit T, Burns A. Cholinesterase inhibitors for dementia with Lewy bodies. Cochrane Database Syst Rev, 2003: CD003672.
8. Maidment I, Fox C, Boustani M. Cholinesterase inhibitors for Parkinson's disease dementia. Cochrane Database Syst Rev, 2006; CD004747.
9. Hogan DB, Bailey P, Carswell A et al. Management of mild to moderate Alzheimer's disease and dementia. Alzheimers Dement 2007 3 : 355 384.
10. Black SE, Doody R, Li H et al. Donepezil preserves cognition and global function in patients with severe Alzheimer disease. Neurology 2007 69 : 459 469.
11. Herrmann N, Gauthier S, Lysy PG. Clinical practice guidelines for severe Alzheimer's disease. Alzheimers Dement 2007 3 : 385 397.
12. Tariot PN, Cummings JL, Katz IR et al. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting. J Am Geriatr Soc 2001 49 : 1590 1599.
13. Winblad B, Kilander L, Eriksson S et al. Donepezil in patients with severe Alzheimer's disease: Double-blind, parallel-group, placebo-controlled study. Lancet 2006 367 : 1057 1065.
14. Gill SS, Bronskill SE, Mamdani M et al. Representation of patients with dementia in clinical trials of donepezil. Can J Clin Pharmacol 2004 11 : e274 e285.
15. Rochon PA, Stukel TA, Bronskill SE et al. Variation in nursing home antipsychotic prescribing rates. Arch Intern Med 2007 167 : 676 683.
16. Gifford DR, Lapane KL, Gambassi G et al. Tacrine use in nursing homes: Implications for prescribing new cholinesterase inhibitors. SAGE Study Group. Systematic Assessment of Geriatric Drug Use via Epidemiology. Neurology 1999 52 : 238 244.
17. Pedone C, Lapane KL, Mor V et al. Donepezil use in US nursing homes. Aging Clin Exp Res 2004 16 : 60 67.
18. Gruber-Baldini AL, Stuart B, Zuckerman IH et al. Treatment of dementia in community-dwelling and institutionalized medicare beneficiaries. J Am Geriatr Soc 2007 55 : 1508 1516.
19. Morris JN, Fries BE, Morris SA. Scaling ADLs within the MDS. J Gerontol A Biol Sci Med Sci 1999 54A : M546 M553.
20. Gruneir A, Lapane KL, Miller SC et al. Is dementia special care really special? A new Look at an old question. J Am Geriatr Soc 2008 56 : 199 205.
21. Lucca U, Nobili A, Riva E et al. Cholinesterase inhibitor use and age in the general population. Arch Neurol 2006 63 : 154 155.
22. Herrmann N, Gill SS, Bell CM et al. A population-based study of cholinesterase inhibitor use for dementia. J Am Geriatr Soc 2007 55 : 1517 1523.
23. Mamdani M, Rapoport M, Shulman KI et al. Mental health-related drug utilization among older adults: Prevalence, trends, and costs. Am J Geriatr Psychiatry 2005 13 : 892 900.
24. Lu S, Hill J, Fillit H. Impact of donepezil use in routine clinical practice on health care costs in patients with Alzheimer's disease and related dementias enrolled in a large medicare managed care plan: A case-control study. Am J Geriatr Pharmacother 2005 3 : 92 102.
25. Sink KM, Holden KF, Yaffe K. Pharmacological treatment of neuropsychiatric symptoms of dementia: A review of the evidence. JAMA 2005 293 : 596 608. (Pubitemid 40171242)
26. Oborne CA, Hooper R, Li KC et al. An indicator of appropriate neuroleptic prescribing in nursing homes. Age Ageing 2002 31 : 435 439.
27. Wu NM, Miller SC, Lapane K et al. The quality of the quality indicator of pain derived from the Minimum Data Set. Health Serv Res 2005 40 : 1197 1216.
28. Mehta KM, Yin M, Resendez C et al. Ethnic differences in acetylcholinesterase inhibitor use for Alzheimer disease. Neurology 2005 65 : 159 162.
29. Linnebur SA, Ruscin JM. Cholinesterase inhibitor use in geriatric outpatients with dementia. Am J Health Syst Pharm 2005 62 : 923 926.
30. Feldman HC, Clarfield AM, Brodsky J et al. An estimate of the prevalence of dementia among residents of long-term care geriatric institutions in the Jerusalem area. Int Psychogeriatr 2006 18 : 643 652.